Skip to content

NYSE · CIK 0001835830

KVYO Klaviyo, Inc.

Insider trading from SEC Form 4. Last filing 3 d ago. Close $17.32 on Oct 9, 2026, +35% from the 52-week low and -48% from the high.

Last 90 days

Net insider value
-$5.0M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
5
$5.0M by 3 insiders
Insiders on file
11
with a Form 4 at this company

Price and insider trades, last year

KVYOOct 9, 2026 · close 17.32

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Klaviyo, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
40ModerateEd Hallen
director, owner
sell
$1.7M
97,482 shares
-104%+35% from low-48% from high
3WeakEd Hallen
director, owner
sell
$22k
1,300 shares
-1%+25% from low-54% from high
16WeakSusan St. Ledger
director
sell
$37k
2,328 shares
-9%-
40ModerateLandon Edmond
Chief Legal Officer
sell
$1.2M
61,576 shares
-11%-
55ModerateEd Hallen
director, owner
sell
$2.0M
98,782 shares
-74%-
58ModerateAndrew Bialecki
Chief Executive Officer
sell
$3.3M
100,000 shares
-100%+40% from low-32% from high
20WeakLandon Edmond
Chief Legal Officer
sell
$445k
14,190 shares
-4%+33% from low-36% from high
58ModerateAndrew Bialecki
Chief Executive Officer
sell
$7.1M
238,648 shares
-172%+24% from low-40% from high
58ModerateAndrew Bialecki
Chief Executive Officer
sell
$6.9M
231,362 shares
-176%+24% from low-40% from high
58ModerateAndrew Bialecki
Chief Executive Officer
sell
$4.1M
142,997 shares
-101%+21% from low-42% from high
65NotableAndrew Bialecki
Chief Executive Officer
sell
$4.0M
144,717 shares
-100%+17% from low-44% from high
26WeakLandon Edmond
Chief Legal Officer
sell
$397k
14,394 shares
-4%+13% from low-45% from high
65NotableAndrew Bialecki
Chief Executive Officer
sell
$4.0M
147,329 shares
-100%+15% from low-44% from high
24WeakCarmel Galvin
Chief People Officer
sell
$307k
11,156 shares
-2%+14% from low-45% from high
65NotableAndrew Bialecki
Chief Executive Officer
sell
$4.2M
140,464 shares
-100%+24% from low-40% from high
50ModerateAndrew Bialecki
Chief Executive Officer
sell
$4.0M
163,331 shares
-100%+0% from low-50% from high
50ModerateAndrew Bialecki
Chief Executive Officer
sell
$4.0M
159,508 shares
-100%+4% from low-48% from high
50ModerateAndrew Bialecki
Chief Executive Officer
sell
$4.0M
137,224 shares
-100%+13% from low-44% from high
65NotableAndrew Bialecki
Chief Executive Officer
sell
$7.5M
211,358 shares
-100%+43% from low-29% from high
65NotableAndrew Bialecki
Chief Executive Officer
sell
$7.3M
226,382 shares
-100%+35% from low-33% from high
45ModerateEd Hallen
director, owner
sell
$2.8M
89,748 shares
-45%+29% from low-36% from high
28WeakStephen Eric Rowland
President
sell
$227k
7,105 shares
-2%+29% from low-36% from high
25WeakSusan St. Ledger
director
sell
$110k
3,413 shares
-24%+27% from low-37% from high
34WeakAmanda Whalen
Chief Financial Officer
sell
$473k
15,000 shares
-3%+28% from low-37% from high
65NotableAndrew Bialecki
Chief Executive Officer
sell
$7.0M
220,481 shares
-100%+31% from low-35% from high
72NotableSummit Partners L P
owner
sell
$127M
4,000,000 shares
-100%+36% from low-33% from high
65NotableAndrew Bialecki
Chief Executive Officer
sell
$6.9M
223,304 shares
-100%+26% from low-37% from high
65NotableAndrew Bialecki
Chief Executive Officer
sell
$7.1M
226,702 shares
-100%+29% from low-36% from high
72NotableSummit Partners L P
owner
sell
$29M
975,000 shares
-100%+29% from low-36% from high
24WeakLandon Edmond
Chief Legal Officer
sell
$313k
9,965 shares
-2%+31% from low-35% from high
25WeakCarmel Galvin
Chief People Officer
sell
$353k
11,155 shares
-2%+31% from low-35% from high
27WeakStephen Eric Rowland
President
sell
$224k
7,105 shares
-2%+31% from low-35% from high
34WeakAmanda Whalen
Chief Financial Officer
sell
$470k
15,000 shares
-3%+29% from low-36% from high
72NotableSummit Partners L P
owner
sell
$195M
6,500,000 shares
-93%+29% from low-36% from high
20WeakStephen Eric Rowland
President
sell
$223k
7,079 shares
-2%+29% from low-36% from high
27WeakAmanda Whalen
Chief Financial Officer
sell
$475k
15,000 shares
-3%+28% from low-36% from high
28WeakStephen Eric Rowland
President
sell
$245k
7,079 shares
-2%+42% from low-30% from high
35WeakAmanda Whalen
Chief Financial Officer
sell
$502k
15,000 shares
-3%+36% from low-32% from high
72NotableSummit Partners L P
owner
sell
$133M
4,000,000 shares
-100%+42% from low-29% from high
72NotableSummit Partners L P
owner
sell
$132M
4,000,000 shares
-100%+41% from low-30% from high
70NotableAndrew Bialecki
Chief Executive Officer
sell
$361M
10,969,078 shares
-100%+44% from low-28% from high
25WeakLandon Edmond
Chief Legal Officer
sell
$347k
9,965 shares
-2%+44% from low-28% from high
26WeakCarmel Galvin
Chief People Officer
sell
$391k
11,156 shares
-2%+44% from low-28% from high
35WeakAmanda Whalen
Chief Financial Officer
sell
$525k
15,000 shares
-3%+44% from low-28% from high
33WeakStephen Eric Rowland
President
sell
$494k
14,139 shares
-3%+43% from low-29% from high
20WeakStephen Eric Rowland
President
sell
$188k
7,060 shares
-2%+3% from low-46% from high
26WeakAmanda Whalen
Chief Financial Officer
sell
$401k
15,000 shares
-3%+5% from low-45% from high
33WeakJeff Fagnan
owner
buy
$101k
3,900 shares
-+13% from low-41% from high
35WeakAmanda Whalen
Chief Financial Officer
sell
$503k
15,000 shares
-4%-
72NotableSummit Partners L P
owner
sell
$65M
2,000,000 shares
-100%-
45ModerateStephen Eric Rowland
President
sell
$1.3M
36,710 shares
-13%-
23WeakLandon Edmond
Chief Legal Officer
sell
$242k
6,222 shares
-2%-
27WeakCarmel Galvin
Chief People Officer
sell
$465k
11,531 shares
-2%-
23WeakAmanda Whalen
Chief Financial Officer
sell
$688k
15,000 shares
-4%-
27WeakStephen Eric Rowland
President
sell
$182k
4,536 shares
-2%-
40ModerateLandon Edmond
Chief Legal Officer
sell
$1.7M
40,000 shares
-12%-
36WeakAmanda Whalen
Chief Financial Officer
sell
$588k
15,000 shares
-4%-
27WeakStephen Eric Rowland
President
sell
$184k
4,536 shares
-2%-
36WeakAmanda Whalen
Chief Financial Officer
sell
$591k
15,000 shares
-4%-
72NotableSummit Partners L P
owner
sell
$82M
2,100,000 shares
-100%-
42ModerateAmanda Whalen
Chief Financial Officer
sell
$1.0M
25,000 shares
-6%-
40ModerateLandon Edmond
Chief Legal Officer
sell
$1.4M
40,000 shares
-14%-
35WeakAmanda Whalen
Chief Financial Officer
sell
$518k
15,000 shares
-4%-
26WeakStephen Eric Rowland
President
sell
$157k
4,536 shares
-2%-
72NotableSummit Partners L P
owner
sell
$114M
3,153,293 shares
-90%-
35WeakJeff Fagnan
owner
buy
$502k
13,515 shares
+142%-
20WeakStephen Eric Rowland
President
sell
$674k
18,114 shares
-9%-

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 7, 2026Ed Hallen
director, owner
SOpen-market sale
Series A Common Stockindirect: By Hodgkins Trust10b5-1
-38,667$17.40$673k55,2903 d ago
Oct 7, 2026Ed Hallen
director, owner
SOpen-market sale
Series A Common Stockindirect: By Hodgkins LLC10b5-1
-58,815$17.40$1.0M388,1313 d ago
Oct 8, 2026Ed Hallen
director, owner
GGift
Series A Common Stockindirect: By Hodgkins LLC10b5-1
-17,885$0.00$0370,2463 d ago
Sep 24, 2026Ed Hallen
director, owner
SOpen-market sale
Series A Common Stockindirect: By Hodgkins Trust10b5-1
-500$17.02$8,51093,95717 d ago
Sep 24, 2026Ed Hallen
director, owner
SOpen-market sale
Series A Common Stockindirect: By Hodgkins LLC10b5-1
-800$17.02$14k446,94617 d ago
Sep 15, 2026Erica Ellen Smith
Chief Financial Officer
AGrant or award
Series A Common Stock
+821,917$0.00$0821,91725 d ago
Sep 15, 2026Erica Ellen Smith
Chief Financial Officer
AGrant or award
Series A Common Stock
+328,767$0.00$01,150,68425 d ago
Sep 11, 2026Susan St. Ledger
director
SOpen-market sale
Series A Common Stock10b5-1
-2,328$15.93$37k23,43328 d ago
Aug 31, 2026Ed Hallen
director, owner
SOpen-market sale
Series A Common Stockindirect: By Hodgkins Trust10b5-1
-39,167$20.47$802k94,45741 d ago
Aug 28, 2026Landon Edmond
Chief Legal Officer
SOpen-market sale
Series A Common Stock10b5-1
-53,473$20.01$1.1M485,96941 d ago
Aug 31, 2026Landon Edmond
Chief Legal Officer
SOpen-market sale
Series A Common Stock10b5-1
-8,103$20.44$166k477,86641 d ago
Aug 31, 2026Ed Hallen
director, owner
SOpen-market sale
Series A Common Stockindirect: By Hodgkins LLC10b5-1
-59,615$20.49$1.2M465,63141 d ago
Aug 31, 2026Ed Hallen
director, owner
GGift
Series A Common Stockindirect: By Hodgkins LLC10b5-1
-17,885$0.00$0447,74641 d ago
Dec 22, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+100,000--100,000Dec 23, 2025
Dec 22, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-93,066$33.05$3.1M6,934Dec 23, 2025
Dec 22, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-6,934$31.94$221k0Dec 23, 2025
Dec 22, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-100,000$0.00$069,568,889Dec 23, 2025
Dec 18, 2025Landon Edmond
Chief Legal Officer
SOpen-market sale
Series A Common Stock10b5-1
-13,718$31.41$431k354,354Dec 19, 2025
Dec 18, 2025Landon Edmond
Chief Legal Officer
SOpen-market sale
Series A Common Stock10b5-1
-472$30.55$14k353,882Dec 19, 2025
Dec 16, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+138,648--138,648Dec 17, 2025
Dec 15, 2025Landon Edmond
Chief Legal Officer
GGift
Series A Common Stock
-8,400$0.00$0368,072Dec 17, 2025
Dec 16, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-138,648$29.04$4.0M0Dec 17, 2025
Dec 17, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+100,000--100,000Dec 17, 2025
Dec 17, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-100,000$30.40$3.0M0Dec 17, 2025
Dec 16, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-138,648$0.00$069,768,889Dec 17, 2025
Dec 17, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-100,000$0.00$069,668,889Dec 17, 2025
Dec 9, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+131,362--131,362Dec 11, 2025
Dec 9, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-130,562$29.42$3.8M800Dec 11, 2025
Dec 9, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-800$28.84$23k0Dec 11, 2025
Dec 10, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+82,223--82,223Dec 11, 2025
Dec 10, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-82,223$30.12$2.5M0Dec 11, 2025
Dec 11, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+17,777--17,777Dec 11, 2025
Dec 11, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-17,777$30.00$533k0Dec 11, 2025
Dec 11, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+3,419,000--3,419,000Dec 11, 2025
Dec 11, 2025Andrew Bialecki
Chief Executive Officer
GGift
Series A Common Stock10b5-1
-3,419,000$0.00$00Dec 11, 2025
Dec 9, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-131,362$0.00$073,426,537Dec 11, 2025
Dec 10, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-82,223$0.00$073,344,314Dec 11, 2025
Dec 11, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-17,777$0.00$073,326,537Dec 11, 2025
Dec 11, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-3,419,000$0.00$069,907,537Dec 11, 2025
Dec 2, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+142,045--142,045Dec 4, 2025
Dec 2, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-142,045$28.62$4.1M0Dec 4, 2025
Dec 4, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+952--952Dec 4, 2025
Dec 4, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-952$30.00$29k0Dec 4, 2025
Dec 2, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-142,045$0.00$073,558,851Dec 4, 2025
Dec 4, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-952$0.00$073,557,899Dec 4, 2025
Nov 24, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+144,717--144,717Nov 26, 2025
Nov 24, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-144,717$27.76$4.0M0Nov 26, 2025
Nov 24, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-144,717$0.00$073,700,896Nov 26, 2025
Nov 20, 2025Landon Edmond
Chief Legal Officer
SOpen-market sale
Series A Common Stock10b5-1
-10,374$27.83$289k380,492Nov 21, 2025
Nov 20, 2025Landon Edmond
Chief Legal Officer
SOpen-market sale
Series A Common Stock10b5-1
-4,020$26.97$108k376,472Nov 21, 2025
Nov 18, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+147,329--147,329Nov 20, 2025
Nov 18, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-147,329$27.16$4.0M0Nov 20, 2025
Nov 18, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-147,329$0.00$073,845,613Nov 20, 2025
Nov 15, 2025Landon Edmond
Chief Legal Officer
CConversion
Series A Common Stock
+11,426--404,010Nov 18, 2025
Nov 15, 2025Gomez Luciano Fernandez
Interim Executive Officer
FTax withholding
Series A Common Stock
-43,533$28.61$1.2M83,852Nov 18, 2025
Nov 15, 2025Carmel Galvin
Chief People Officer
FTax withholding
Series A Common Stock10b5-1
-24,817$28.61$710k651,016Nov 18, 2025
Nov 17, 2025Carmel Galvin
Chief People Officer
SOpen-market sale
Series A Common Stock10b5-1
-7,120$27.74$198k643,896Nov 18, 2025
Nov 15, 2025Landon Edmond
Chief Legal Officer
FTax withholding
Series A Common Stock
-24,218$28.61$693k379,792Nov 18, 2025
Nov 17, 2025Landon Edmond
Chief Legal Officer
CConversion
Series A Common Stock
+11,074--390,866Nov 18, 2025
Nov 17, 2025Carmel Galvin
Chief People Officer
SOpen-market sale
Series A Common Stock10b5-1
-4,036$27.11$109k639,860Nov 18, 2025
Nov 15, 2025Landon Edmond
Chief Legal Officer
CConversion
Series B Common Stockderivative
-11,426$0.00$033,574Nov 18, 2025
Nov 17, 2025Landon Edmond
Chief Legal Officer
CConversion
Series B Common Stockderivative
-11,074$0.00$022,500Nov 18, 2025
Nov 11, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+140,464--140,464Nov 13, 2025
Nov 11, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-140,464$29.74$4.2M0Nov 13, 2025
Nov 11, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-140,464$0.00$073,992,942Nov 13, 2025
Oct 14, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+163,331--163,331Oct 16, 2025
Oct 14, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-163,331$24.37$4.0M0Oct 16, 2025
Oct 14, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-163,331$0.00$074,133,406Oct 16, 2025
Oct 7, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+159,508--159,508Oct 9, 2025
Oct 7, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-144,890$25.32$3.7M14,618Oct 9, 2025
Oct 7, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-14,618$25.07$366k0Oct 9, 2025
Oct 7, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-159,508$0.00$074,296,737Oct 9, 2025
Sep 30, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+137,224--137,224Oct 2, 2025
Sep 30, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-17,960$31.24$561k119,264Oct 2, 2025
Sep 30, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-6,048$30.28$183k113,216Oct 2, 2025
Sep 30, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-44,672$29.03$1.3M68,544Oct 2, 2025
Sep 30, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-39,733$28.22$1.1M28,811Oct 2, 2025
Sep 30, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-28,811$27.70$798k0Oct 2, 2025
Sep 30, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-137,224$0.00$074,456,245Oct 2, 2025
Sep 23, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+211,358--211,358Sep 25, 2025
Sep 23, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-181,553$35.52$6.4M29,805Sep 25, 2025
Sep 23, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-29,805$35.01$1.0M0Sep 25, 2025
Sep 23, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-211,358$0.00$074,593,469Sep 25, 2025
Sep 16, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series A Common Stock10b5-1
+226,382--226,382Sep 17, 2025
Sep 15, 2025Gomez Luciano Fernandez
Interim Executive Officer
AGrant or award
Series A Common Stock
+100,597$0.00$0127,385Sep 17, 2025
Sep 15, 2025Ed Hallen
director, owner
SOpen-market sale
Series A Common Stockindirect: By Hodgkins Trust10b5-1
-22,224$31.65$703k177,776Sep 17, 2025
Sep 15, 2025Stephen Eric Rowland
President
SOpen-market sale
Series A Common Stock10b5-1
-6,905$31.90$220k438,821Sep 17, 2025
Sep 16, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-140,921$32.71$4.6M85,461Sep 17, 2025
Sep 15, 2025Ed Hallen
director, owner
SOpen-market sale
Series A Common Stockindirect: By Hodgkins LLC10b5-1
-67,524$31.73$2.1M722,476Sep 17, 2025
Sep 15, 2025Stephen Eric Rowland
President
SOpen-market sale
Series A Common Stock10b5-1
-200$31.24$6,248438,621Sep 17, 2025
Sep 16, 2025Andrew Bialecki
Chief Executive Officer
SOpen-market sale
Series A Common Stock10b5-1
-85,461$31.76$2.7M0Sep 17, 2025
Sep 15, 2025Ed Hallen
director, owner
GGift
Series A Common Stockindirect: By Hodgkins LLC10b5-1
-20,260$0.00$0702,216Sep 17, 2025
Sep 16, 2025Andrew Bialecki
Chief Executive Officer
CConversion
Series B Common Stockderivative10b5-1
-226,382$0.00$074,804,827Sep 17, 2025
Sep 12, 2025Amanda Whalen
Chief Financial Officer
CConversion
Series A Common Stock10b5-1
+11,204--496,719Sep 12, 2025
Sep 10, 2025Susan St. Ledger
director
SOpen-market sale
Series A Common Stock10b5-1
-3,413$32.20$110k10,939Sep 12, 2025
Sep 11, 2025Ed Hallen
director, owner
CConversion
Series A Common Stock
+990,000--990,000Sep 12, 2025
Sep 12, 2025Amanda Whalen
Chief Financial Officer
SOpen-market sale
Series A Common Stock10b5-1
-15,000$31.50$473k481,719Sep 12, 2025
Sep 11, 2025Ed Hallen
director, owner
GGift
Series A Common Stock
-990,000$0.00$00Sep 12, 2025
Sep 12, 2025Amanda Whalen
Chief Financial Officer
CConversion
Series B Common Stockderivative10b5-1
-11,204$0.00$0408,476Sep 12, 2025
Sep 11, 2025Ed Hallen
director, owner
GGift
Series A Common Stockindirect: By Hodgkins Trust
+200,000$0.00$0200,000Sep 12, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

KVYO insider trading: Klaviyo, Inc. | InsiderTell